Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lulzim Shkreta

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Vaccine|January 24, 2006
DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureusAdel N M Nour El-Din, Lulzim Shkreta, Brian G Talbot, et al.
Vaccine|May 16, 2002
DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureusEric Brouillette, Pierre Lacasse, Lulzim Shkreta, et al.
Brain : a Journal of Neurology|October 27, 2018
Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing functionMartine Tétreault, Jade-Emmanuelle Deshaies, Sabrina Semmler, et al.
Nucleic Acids Research|December 31, 2013
Redirecting splicing with bifunctional oligonucleotidesJean-Philippe Brosseau, Jean-François Lucier, Andrée-Anne Lamarche, et al.
Nucleic Acids Research|December 9, 2016
Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replicationLulzim Shkreta, Marco Blanchette, Johanne Toutant, et al.
Viruses|January 25, 2025
Exploiting the Achilles' Heel of Viral RNA Processing to Develop Novel AntiviralsAli Zahedi Amiri, Choudhary Ahmed, Subha Dahal, et al.
Molecular and Cellular Biology|December 29, 2011
Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulatorsLaetitia Michelle, Alexandre Cloutier, Johanne Toutant, et al.
NAR Cancer|July 28, 2021
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cellsMuhammad Sohail, Lulzim Shkreta, Johanne Toutant, et al.
Oncotarget|May 16, 2024
The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune responseLulzim Shkreta, Johanne Toutant, Aurélie Delannoy, et al.
Retrovirology|August 19, 2022
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latencySubha Dahal, Kiera Clayton, Terek Been, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Vaccine|January 24, 2006
DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureusAdel N M Nour El-Din, Lulzim Shkreta, Brian G Talbot, et al.
Vaccine|May 16, 2002
DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureusEric Brouillette, Pierre Lacasse, Lulzim Shkreta, et al.
Brain : a Journal of Neurology|October 27, 2018
Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing functionMartine Tétreault, Jade-Emmanuelle Deshaies, Sabrina Semmler, et al.
Nucleic Acids Research|December 31, 2013
Redirecting splicing with bifunctional oligonucleotidesJean-Philippe Brosseau, Jean-François Lucier, Andrée-Anne Lamarche, et al.
Nucleic Acids Research|December 9, 2016
Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replicationLulzim Shkreta, Marco Blanchette, Johanne Toutant, et al.
Viruses|January 25, 2025
Exploiting the Achilles' Heel of Viral RNA Processing to Develop Novel AntiviralsAli Zahedi Amiri, Choudhary Ahmed, Subha Dahal, et al.
Molecular and Cellular Biology|December 29, 2011
Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulatorsLaetitia Michelle, Alexandre Cloutier, Johanne Toutant, et al.
NAR Cancer|July 28, 2021
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cellsMuhammad Sohail, Lulzim Shkreta, Johanne Toutant, et al.
Oncotarget|May 16, 2024
The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune responseLulzim Shkreta, Johanne Toutant, Aurélie Delannoy, et al.
Retrovirology|August 19, 2022
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latencySubha Dahal, Kiera Clayton, Terek Been, et al.
Pageof 4